OTC Pharmaceuticals - Canada

  • Canada
  • Revenue in the OTC Pharmaceuticals market amounts to €3,332.00m in 2024. The market is expected to grow annually by 4.15% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of €905.40m in 2024.
  • In global comparison, most revenue is generated in the United States (€37,700m in 2024).
  • In relation to total population figures, per person revenues of €85.21 are generated in 2024.
  • In the OTC Pharmaceuticals market, 31.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Comparaison de régions

Analyst Opinion

The OTC Pharmaceuticals market in Canada has experienced significant growth in recent years, driven by several key factors.

Customer preferences:
Canadian consumers have shown a growing preference for self-care and self-medication, which has contributed to the increasing demand for OTC pharmaceuticals. This trend is driven by several factors, including convenience, cost-effectiveness, and a desire for greater control over their own healthcare. Additionally, the aging population in Canada has also played a role in driving the demand for OTC pharmaceuticals, as older adults often require medications for chronic conditions that can be managed with over-the-counter products.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Canada is the increasing availability and variety of products. Canadian consumers have access to a wide range of OTC medications, including pain relievers, cough and cold remedies, digestive aids, and allergy medications. This variety allows consumers to choose products that best meet their individual needs and preferences. Another trend in the market is the growing popularity of natural and herbal remedies. Many consumers are seeking alternatives to traditional pharmaceuticals and are turning to natural products for their healthcare needs.

Local special circumstances:
One of the unique aspects of the OTC Pharmaceuticals market in Canada is the role of the government in regulating these products. Health Canada, the country's regulatory agency, is responsible for ensuring the safety and efficacy of OTC medications. This includes reviewing and approving new products, monitoring adverse events, and providing guidance to manufacturers and consumers. The strict regulations in place help to ensure that Canadian consumers have access to safe and effective OTC medications.

Underlying macroeconomic factors:
Several macroeconomic factors have contributed to the growth of the OTC Pharmaceuticals market in Canada. The country's strong economy and high disposable income levels have allowed consumers to spend more on healthcare products, including OTC medications. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, has also driven the demand for OTC pharmaceuticals. As these conditions become more common, consumers are seeking products that can help them manage their symptoms and improve their quality of life. In conclusion, the OTC Pharmaceuticals market in Canada has experienced significant growth in recent years, driven by factors such as customer preferences for self-care, the availability of a wide range of products, and the role of the government in regulating these products. The market is expected to continue to grow as Canadian consumers increasingly seek out OTC medications for their healthcare needs.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Key Players
  • Analyst Opinion
  • Demographics
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter


Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Temitope Ifekoya
Temitope Ifekoya
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)